(Date:12/15/2009)... China Sky One,Medical, Inc. ("China Sky One Medical" ... fully integrated pharmaceutical company developing and producing,over-the-counter drugs ... that the Company has 30 medicines that will ... Basic Medical Insurance, Industrial Injury Insurance,and Maternity Insurance ... 30 medicines treat a variety of common ailments ...
(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and ... at the liquid/air interface. The NeedleProbes’ cylindrical geometry enables ... rate and viscosity - all in a single force distance ... ... 2009 -- New, constant diameter NeedleProbes are enabling ...
(Date:12/15/2009)... On January 20th, 2010, the inaugural ... Publication Professionals (ISMPP) will be held at the ... than 100 attendees are expected at this prestigious ... editors, publishers, medical writers and medical agencies to ... the impact of guidelines and regulations such as ...
(Date:12/14/2009)... OAKS, Calif., Dec. 14 Array BioPharma ... AMGN ) today announced that they entered ... to Array,s small-molecule glucokinase activator program, including ARRY-403, ... trial in patients with Type 2 diabetes. ... Array will receive an upfront payment of $60 ...
Breaking Biology Technology:China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7... (Nasdaq and MTAX: CTIC) today announced that it ... indicating that the Company,s,recently completed registered offering of ... Preferred") and warrants did not comply with voting,rights ... and IM 4351.,The Nasdaq staff verbally notified the ...
... - ... - Company Plans ... Inc.,(PDL) (Nasdaq: PDLI ) today announced a significant strategic change ... in,oncology and select immunological diseases, following a months-long,business and portfolio review. ...
... Saporta,approved the consolidated financial statements at 30 June 2007: (EUR millions) 2007 ... HY1 sales ... 74.8 100.0 64.2 100.0 17 Cost of ... Gross profit 57.9 77.5 49.6 ...
Other Biology Technology:Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination 2PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 2PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 3PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 4PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 5STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30% 2, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Request Info...
Ms anti-Cyclophilin D...
...
Biology Products:Biology NavigationMedical Navigation